In an educational session here at the American Society for Dermatologic Surgery annual meeting, Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, provided an update on squamous cell carcinoma, including how to prevent patients from entering the high-risk category and available treatment options.
“One of the reasons I became a Mohs surgeon was to get to live in the happy world where we enjoy our 99% cure rate,” Schmults said. “I didn’t want to be an oncologist because I cry too easily. … I didn’t really want to see patients having really extreme disease. But in my first year as an attending at Penn, I had this lady with extreme tumors, and I was worried I wouldn’t be able to successfully control them.”